- Home
- ELTX vs IAE Comparison
ELTX vs IAE Comparison
Compare ELTX & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- IAE
- Stock Information
- Founded
- ELTX 2011
- IAE 2007
- Country
- ELTX United States
- IAE United States
- Employees
- ELTX N/A
- IAE N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- IAE Trusts Except Educational Religious and Charitable
- Sector
- ELTX Health Care
- IAE Finance
- Exchange
- ELTX Nasdaq
- IAE Nasdaq
- Market Cap
- ELTX 49.7M
- IAE 71.1M
- IPO Year
- ELTX 2021
- IAE N/A
- Fundamental
- Price
- ELTX $4.77
- IAE $6.58
- Analyst Decision
- ELTX Buy
- IAE
- Analyst Count
- ELTX 2
- IAE 0
- Target Price
- ELTX $10.00
- IAE N/A
- AVG Volume (30 Days)
- ELTX 14.5K
- IAE 46.3K
- Earning Date
- ELTX 11-07-2024
- IAE 01-01-0001
- Dividend Yield
- ELTX N/A
- IAE 10.21%
- EPS Growth
- ELTX N/A
- IAE N/A
- EPS
- ELTX N/A
- IAE N/A
- Revenue
- ELTX N/A
- IAE N/A
- Revenue This Year
- ELTX N/A
- IAE N/A
- Revenue Next Year
- ELTX N/A
- IAE N/A
- P/E Ratio
- ELTX N/A
- IAE N/A
- Revenue Growth
- ELTX N/A
- IAE N/A
- 52 Week Low
- ELTX $2.96
- IAE $5.31
- 52 Week High
- ELTX $11.45
- IAE $6.45
- Technical
- Relative Strength Index (RSI)
- ELTX 51.83
- IAE 47.79
- Support Level
- ELTX $4.39
- IAE $6.55
- Resistance Level
- ELTX $5.00
- IAE $6.73
- Average True Range (ATR)
- ELTX 0.26
- IAE 0.08
- MACD
- ELTX -0.03
- IAE -0.03
- Stochastic Oscillator
- ELTX 51.74
- IAE 8.33
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.